UnitedHealthcare Pharmacy
Clinical Pharmacy Programs
Program Number 2025 P 1192-10
Program Prior Authorization/Notification
Medications Xuriden® (uridine triacetate)
P&T Approval Date 6/2016, 6/2017, 6/2018, 6/2019, 6/2020, 6/2021, 6/2022, 6/2023,
6/2024, 6/2025
Effective Date 9/1/2025
1. Background:
Xuriden® (uridine triacetate) is a pyrimidine analog for uridine replacement indicated in adult
and pediatric patients for the treatment of hereditary orotic aciduria.
2. Coverage Criteriaa:
A. Initial Authorization
1. Xuriden will be approved based on the following criterion:
a. Diagnosis of hereditary orotic aciduria
Authorization will be issued for 12 months.
B. Reauthorization
1. Xuriden will be approved based on the following criterion:
a. Documentation of positive clinical response to Xuriden therapy
Authorization will be issued for 12 months.
a State mandates may apply. Any federal regulatory requirements and the member specific
benefit plan coverage may also impact coverage criteria. Other policies and utilization
management programs may apply.
3. Additional Clinical Programs:
• Notwithstanding Coverage Criteria, UnitedHealthcare may approve initial and re-
authorization based solely on previous claim/medication history, diagnosis codes (ICD-10)
and/or claim logic. Use of automated approval and re-approval processes varies by program
and/or therapeutic class.
• Supply limitations may be in place
4. References:
1. Xuriden [package insert]. West Conshohocken, PA: BTG International Inc.; August 2023.
© 2025 UnitedHealthcare Services, Inc.
1
Program Prior Authorization/Notification – Xuriden® (uridine triacetate)
Change Control
6/2016 New program.
6/2017 Annual review with no changes to criteria. Updated reference.
6/2018 Annual review with no changes to criteria.
6/2019 Annual review with no changes to criteria.
6/2020 Annual review with no changes to criteria.
6/2021 Annual review with no changes to criteria.
6/2022 Annual review. Changed reauthorization to 12 months to align with
reauthorization period for other pharmacy programs. Updated
background and reference.
6/2023 Annual review with no change to criteria. Updated reference formatting
and added state mandate footnote.
6/2024 Annual review with no change to criteria. Updated reference.
6/2025 Annual review with no changes to criteria.
© 2025 UnitedHealthcare Services, Inc.
2